Related Experiment Video

Updated: Sep 30, 2026

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

K252a inhibits the oncogenic properties of Met, the HGF receptor

Alessandro Morotti1, Silvia Mila, Paolo Accornero

  • 1Department of Anatomy, Pharmacology and Forensic Medicine, University of Turin, C.so Massimo d'Azeglio 52, 10126 Turin, Italy.

Oncogene
|July 16, 2002
PubMed

Insights

The ATP analog K252a effectively inhibits Met receptor tyrosine kinase activity, blocking cancer cell proliferation and metastasis. This suggests K252a derivatives hold promise for treating Met-mediated tumors.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Pharmacology

Background:

  • Receptor tyrosine kinases (RTKs) play crucial roles in cell signaling and cancer development.
  • The Trk family and the Met receptor are key RTKs implicated in various malignancies.
  • Inhibitors targeting RTKs are vital for cancer therapy.

Purpose of the Study:

  • To investigate the inhibitory effects of K252a on Met receptor tyrosine kinase.
  • To evaluate K252a's efficacy in blocking Met-driven cellular processes and tumor formation.
  • To explore K252a's potential as a therapeutic agent for Met-mediated cancers.

Main Methods:

  • Treatment of various cell lines (MLP-29, GTL-16, NIH3T3) with K252a at nanomolar concentrations.
  • Assessment of Met autophosphorylation and downstream effector activation (MAPK, Akt).
  • In vivo studies using nude mice to evaluate K252a's effect on lung metastasis formation.

Main Results:

  • K252a inhibited HGF-mediated scattering, Met-driven proliferation, and Tpr-Met-induced transformation in a dose-dependent manner.
  • K252a effectively blocked Met autophosphorylation and downstream signaling pathways.
  • K252a demonstrated greater efficacy against a mutated form of Met found in kidney papillary carcinoma.
  • Pretreatment with K252a significantly reduced lung metastasis formation in vivo.
  • K252a inhibited Met signaling in both cultured cells and immunoprecipitates.

Conclusions:

  • K252a is a potent inhibitor of Met receptor tyrosine kinase activity.
  • K252a demonstrates anti-proliferative and anti-metastatic effects in preclinical models of Met-driven cancers.
  • K252a derivatives warrant further investigation as potential anti-cancer drugs for Met-mediated tumors.

More Related Videos

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...